Geneva Capital Management LLC Edwards Lifesciences Corp Transaction History

Geneva Capital Management LLC

$5.88 Billion
Q3 2024

A detailed history of Geneva Capital Management LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Geneva Capital Management LLC holds 16,322 shares of EW stock, worth $1.21 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

16,322

Previous 17,737 7.98%

Holding current value

$1.21 Million

Previous $1.64 Million 34.25%

% of portfolio

0.02%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$59.7 - $93.78 $84,475 - $132,698	-1,415 Reduced 7.98%	16,322 $1.08 Million
Q2 2024 Aug 14, 2024	BUY	$84.3 - $94.31 $1.5 Million - $1.67 Million	17,737 New	17,737 $1.64 Million
Q1 2024 May 03, 2024	SELL	$72.54 - $95.56 $80,084 - $105,498	-1,104 Reduced 4.75%	22,158 $2.12 Million
Q4 2023 Feb 06, 2024	SELL	$61.71 - $77.76 $71,892 - $90,590	-1,165 Reduced 4.77%	23,262 $1.77 Million
Q3 2023 Nov 13, 2023	SELL	$69.28 - $93.38 $649,707 - $875,717	-9,378 Reduced 27.74%	24,427 $1.69 Million
Q2 2023 Aug 01, 2023	SELL	$81.41 - $94.33 $115,846 - $134,231	-1,423 Reduced 4.04%	33,805 $3.19 Million
Q1 2023 May 12, 2023	SELL	$74.26 - $84.51 $194,709 - $221,585	-2,622 Reduced 6.93%	35,228 $2.91 Million
Q4 2022 Feb 07, 2023	BUY	$68.3 - $87.44 $88,038 - $112,710	1,289 Added 3.53%	37,850 $2.82 Million
Q3 2022 Nov 02, 2022	BUY	$82.37 - $107.29 $3.01 Million - $3.92 Million	36,561 New	36,561 $3.02 Million
Q2 2022 Aug 02, 2022	SELL	$86.5 - $128.27 $34,859 - $51,692	-403 Reduced 1.09%	36,573 $3.48 Million
Q1 2022 May 02, 2022	BUY	$101.96 - $128.34 $42,823 - $53,902	420 Added 1.15%	36,976 $4.35 Million
Q4 2021 Feb 02, 2022	SELL	$106.37 - $130.68 $94,988 - $116,697	-893 Reduced 2.38%	36,556 $4.74 Million
Q3 2021 Nov 08, 2021	SELL	$102.91 - $122.75 $111,451 - $132,938	-1,083 Reduced 2.81%	37,449 $4.24 Million
Q2 2021 Aug 11, 2021	SELL	$83.84 - $104.76 $14,001 - $17,494	-167 Reduced 0.43%	38,532 $3.99 Million
Q1 2021 May 03, 2021	BUY	$78.68 - $90.67 $356,341 - $410,644	4,529 Added 13.25%	38,699 $3.24 Million
Q4 2020 Feb 02, 2021	BUY	$71.69 - $91.23 $2,580 - $3,284	36 Added 0.11%	34,170 $3.12 Million
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $20,761 - $27,018	309 Added 0.91%	34,134 $2.73 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $1.3 Million - $1.74 Million	22,650 Added 202.68%	33,825 $2.34 Million
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $585,681 - $905,175	11,175 New	11,175 $2.11 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneva Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geneva Capital Management LLC with notifications on news.

Account

Geneva Capital Management LLC Edwards Lifesciences Corp Transaction History